Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.36 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.36 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.36 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.36 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.36 |
| ▸ | DRD1 | P21728 | 1/20 | 0.36 |
| ▸ | HRH2 | P25021 | 1/20 | 0.36 |
| ▸ | HTR2A | P28223 | 1/20 | 0.36 |
| ▸ | HTR2C | P28335 | 1/20 | 0.36 |
| ▸ | HRH1 | P35367 | 1/20 | 0.36 |
| ▸ | DRD3 | P35462 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29726715 | 0.94 | MAPT (0.42) | NPSR1MAPTCYP3A4LMNACYP1A2 | |
| SCHEMBL1709532 | 0.88 | CYP3A4 (0.45) | NPSR1MAPTCYP3A4LMNACYP1A2 | |
| SCHEMBL20103712 | 0.84 | CYP3A4 (0.50) | NPSR1MAPTCYP3A4LMNACYP1A2 | |
| SCHEMBL15282862 | 0.83 | ALDH1A1 (0.33) | NPSR1MAPTCYP3A4LMNACYP1A2 | |
| SCHEMBL2833742 | 0.82 | CYP3A4 (0.44) | NPSR1MAPTCYP3A4LMNACYP1A2 | |
| SCHEMBL4002175 | 0.81 | CYP3A4 (0.32) | NPSR1CYP3A4LMNACYP1A2ABCB11 | |
| SCHEMBL11858353 | 0.80 | CYP3A4 (0.54) | NPSR1MAPTCYP3A4LMNACYP1A2 | |
| SCHEMBL20054732 | 0.80 | CYP3A4 (0.50) | NPSR1MAPTCYP3A4LMNACYP1A2 | |
| SCHEMBL17868702 | 0.79 | CYP3A4 (0.47) | NPSR1CYP3A4LMNACYP1A2ABCB11 | |
| SCHEMBL18814945 | 0.79 | CYP3A4 (0.47) | NPSR1CYP3A4LMNACYP1A2ABCB11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117800987-B | Cephalosporin compound and application thereof in preparation of antibacterial drugs | 复旦大学 | 2026-05-19 | — | — | CN | disclosed |
| CN-118451079-A | Benzopiperidine derivative modulators, methods of preparation and uses thereof | 上海翰森生物医药科技有限公司 | 2024-08-06 | — | — | CN | disclosed |
| CN-117800987-A | Cephalosporin compound and application thereof in preparation of antibacterial drugs | 复旦大学 | 2024-04-02 | — | — | CN | disclosed |
| WO-2023125935-A1 | BENZOPYRIDINE DERIVATIVE REGULATOR, AND PREPARATION METHOD THEREFOR AND USE THEREOF | 上海翰森生物医药科技有限公司 | 2023-07-06 | — | — | WO | disclosed |
| WO-2023125935-A1 | BENZOPYRIDINE DERIVATIVE REGULATOR, AND PREPARATION METHOD THEREFOR AND USE THEREOF | 上海翰森生物医药科技有限公司 | 2023-07-06 | — | — | WO | disclosed |
| US-20230135215-A1 | COMPOUNDS AS CDK2/4/6 INHIBITORS | FOCHON BIOSCIENCES, LTD. (CN) | 2023-05-04 | — | — | US | disclosed |
| EP-4110782-A1 | COMPOUNDS AS CDK2/4/6 INHIBITORS | Fochon Biosciences, Ltd. (CN) | 2023-01-04 | — | — | EP | disclosed |
| CN-115551856-A | Compounds as CDK2/4/6 inhibitors | 重庆复尚源创医药技术有限公司 | 2022-12-30 | — | — | CN | disclosed |
| EP-1601646-A2 | 2-SUBSTITUTED VITAMIN D ANALOGUES AND THEIR THERAPEUTIC USES | K.U. Leuven Research and Development (BE) | 2005-12-07 | — | — | EP | disclosed |
| WO-2004080922-A2 | SUBSTITUTED VITAMIN D ANALOGUES AND THEIR THERAPEUTIC USES | K.U. LEUVEN RESEARCH & DEVELOPMENT (BE) | 2004-09-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230135215-A1 | COMPOUNDS AS CDK2/4/6 INHIBITORS | CDK2, CDK6, CDK20 | NPSR1 4675/4885MAPT 2321/4885CYP3A4 659/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.